In rodent models of cardiac hypertrophy, treatment with sEH inhibitors decreased atrial and ventricular arrhythmias and effectively reduced isoproterenol-induced cardiac hypertrophy (Monti et al., 2008; Sirish et al., 2013). The gene discussed is EPHX2; the disease is cardiac hypertrophy.